Imagion Biosystems has released Appendix 3Y Change of Director’s Interest Notice. Read Appendix 3Y.
Positive independent review sets priority path to market for MagSense® Technology
Highlights Blinded review by panel of expert breast radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance